6th Mar 2009 16:02
RNS Number : 4827O
Cyprotex PLC
06 March 2009
6 March 2009
Cyprotex PLC ('Cyprotex' or the 'Company')
Notification of Interest
The Company was informed on 5 March 2009 that Mr Richard Sneller, following the acquisition of 100,000 ordinary shares in Cyprotex, had a beneficial interest of 5,400,000 ordinary shares in the Company, representing approximately 3.02% of the issued share capital of the Company.
|
Enquiries: Cyprotex PLC |
|
|
Tony Baxter, CEO |
01625 505 100 |
|
Mark Warburton, Company Secretary
|
|
|
Noble & Company Limited |
|
|
John Llewellyn-Lloyd |
020 7763 2200 |
|
Sam Reynolds |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
CRX.L